Non-invasive monitoring of hepatocellular carcinoma in transgenic mouse with bioluminescent imaging

Cancer Letters

Volumn 310, Issue 1, 2011, Pages 53-60

  Park, Ju Hui ^a,c   Kim, Kwang Il ^a   Lee, Yong Jin ^a   Lee, Tae Sup ^a   Kim, Kyeong Min ^a   Nahm, Sang Soep ^b   Park, Young Seo ^c   Cheon, Gi Jeong ^a   Lim, Sang Moo ^a   Kang, Joo Hyun ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Konkuk University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

Author keywords

Fetoprotein; Hepatocellular carcinoma; Luciferase; Molecular imaging; Transgenic mouse

Indexed keywords

ALPHA FETOPROTEIN; FIREFLY LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; EMBRYO; ENHANCER REGION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; MOLECULAR IMAGING; MOUSE; NEWBORN; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

ALPHA-FETOPROTEINS; ANIMALS; ANIMALS, NEWBORN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DIETHYLNITROSAMINE; FEMALE; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR IMAGING; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; MUS MUSCULUS;

EID: 79961126545     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.06.013     Document Type: Article

References (24)

1. Anthony P. Tumours and tumour-like lesions of the liver and biliary tract: aetiology, epidemiology and pathology. Pathology of the Liver 2002, 711-775. Churchill Livingstone, New York. R. MacSween, A. Burt, B. Portmann, K. Ishak, P. Scheuer, P. Anthony (Eds.).
2. Tanaka S., Arii S. Molecularly targeted therapy for hepatocellular carcinoma. Cancer Sci. 2009, 100:1-8.
3. Motola-Kuba D., Zamora-Valdes D., Uribe M., Mendez-Sanchez N. Hepatocellular carcinoma: an overview. Ann. Hepatol. 2006, 5:16-24.
4. But D.Y., Lai C.L., Yuen M.F. Natural history of hepatitis related hepatocellular carcinoma. World J Gastroenterol. 2008, 14:1652-1656.
5. Aguayo A., Patt Y.Z. Liver cancer. Clin Liver Dis. 2001, 5:479-507.
6. Abelev G.I., Perova S.D., Khrankova N.I., Postnikova Z.A., Irlin I.S. Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation 1963, 1:174-180.
7. Nakabayashi H., Koyama Y., Suzuki H. Functional mapping of tissue-specific elements of the human α-fetoprotein gene enhancer. Biochem. Biophys. Res. Commun. 2004, 318:773-785.
8. Watanabe K., Saito A., Tamaoki T. Cell-specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene. J. Biol. Chem. 1987, 262:4812-4818.
9. Abelev G.I. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv. Cancer Res. 1971, 14:295-358.
10. Alpert E. Human a 1-fetoprotein (AFP): developmental biology and clinical significance. Prog. Liver Dis. 1976, 5:337-349.
11. Spear B.T. Alpha-fetoprotein gene regulation: lessons from transgenic mice. Semin. Cancer Biol. 1999, 9:109-116.
12. Goldfarb S., Pugh T.D., Koen H., He Y.Z. Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy. Environ. Health Perspect. 1983, 50:149-161.
13. Koen H., Pugh T.D., Nychka D., Goldfarb S. Presence of alpha-fetoprotein-positive cells in hepatocellular foci and microcarcinomas induced by single injections of diethylnitrosamine in infant mice. Cancer Res. 1983, 43:702-708.
14. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317:121-124.
15. Contag C.H., Jenkins D., Contag P.R., Negrin R.S. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000, 2:41-52.
16. Cao Y.A., Wagers A.J., Beilhack A., Dusich J., Bachmann M.H., Negrin R.S., Weissman I.L., Contag C.H. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl. Acad. Sci. 2004, 101:221-226.
17. Herschman H.R. Noninvasive imaging of reporter gene expression in living subjects. Adv. Cancer Res. 2004, 92:29-80.
18. Kang J.H., Chung J.K. Molecular-genetic imaging based on reporter gene expression. J. Nucl. Med. 2008, 49:164-179.
19. Zhang L., Adams J.Y., Billick E., Ilagan R., Iyer M., Le K., Smallwood A., Gambhir S.S., Carey M., Wu L. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol. Ther. 2002, 5:223-232.
20. Ilagan R., Zhang L.J., Pottratz J., Le K., Salas S., Iyer M., Wu L., Gambhir S.S., Carey M. Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model. Mol. Cancer Ther. 2005, 4:1662-1669.
21. Maggi A., Ottobrini L., Biserni A., Lucignani G., Ciana P. Techniques: reporter mice-a new way to look at drug action. Trends Pharmacol. Sci. 2004, 25:337-342.
22. Kwon G.S., Fraser S.T., Eakin G.S., Mangano M., Isern J., Sahr K.E., Hadjantonakis A.K., Baron M.H. Tg(Afp-GFP) expression marks primitive and definitive endoderm lineages during mouse development. Dev. Dynam. 2006, 235:2549-2558.
23. Cany J., Avril A., Pichard V., Aubert D., Ferry N., Conchon S. A transgenic mouse with β-galactosidase as a fetal liver self-antigen for immunotherapy studies. J. Hepatol. 2007, 47:396-403.
24. Iyer M., Salazar F.B., Lewis X., Zhang L., Wu L., Carey M., Gambhir S.S. Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy. Transgenic Res. 2005, 14:47-55.